## FISV: Fiserv, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.52 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-2.4% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($60.89)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 12 ($2.47M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (-2.9%)
- Blackrock Inc.: 7.5% (+0.6%)
- Dodge & Cox Inc.: 7.2% (+30.0%)
- Capital World Invest: 4.8% (+35.2%)
- State Street Corpora: 4.4% (-1.8%)

### Key Risks

1. Long-term trend broken: trading 56.3% below SMA200.
2. Falling knife pattern: rapid decline without stabilization, catch risk elevated.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.52 indicates undervaluation relative to growth. Balance sheet: $1.3B free cash flow. Insider buying signal ($2.5M), management confidence. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.0B |
| Beta | 1.00 |
| 52W Range | $59.56 - $238.59 |
| Short Interest | 0.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.52 |
| Forward P/E | 7.9 |
| Current P/E | 7.7 |
| YoY Growth | -2.5% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from 5.0% to 2.6% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 1.4pp (needs >4.0% for momentum thesis). MRS_5 (-0.2%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.8% shows strong absolute momentum above own 20MA. Below SMA200 (0.44x), long-term trend not supportive. MACD histogram positive (2.69), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.61% (CS: 75) | Neutral |
| RSI_14 | 37.2 | Neutral |
| MACD Histogram | 2.69 | Bullish |
| vs SMA20 | 1.048x | Above |
| vs SMA50 | 0.741x | Below |
| vs SMA200 | 0.437x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $66.21
- **Stop Loss:** $60.89 (8.0% risk)
- **Target:** $76.85 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 225
- **Position Value:** $14,897.25
- **Portfolio %:** 14.90%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-04 (Est: $1.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.65 | $2.04 | -22.9% |
| 2025Q2 | $2.43 | $2.47 | +1.5% |
| 2025Q1 | $2.08 | $2.14 | +3.1% |
| 2024Q4 | $2.48 | $2.51 | +1.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*